Minister defends animal testing lab plan
A MALAYSIAN minister defended an Indian company's plans to build an animal testing medicine lab in his state, saying yesterday that God created monkeys and rats for experiments to benefit humans.
The plans by India's Vivo BioTech Ltd to set up a biotechnology center in southern Malacca state has come under fire by activists because it will conduct tests on dogs and primates to make medicines. The activists said Malaysia has no regulations on animal research, which could lead to test subjects being abused.
But Malacca Chief Minister Mohamad Ali Rustam said the lab had received state approval, and animal testing was necessary to make drugs. The project is still in the planning phase.
"God created animals for the benefits of human beings. That's why he created rats and monkeys ... We cannot test on human beings," he said. "This is the way it has to be. God created monkeys, and some have to be tested."
He said Malaysian agencies, such as the wildlife department, could monitor that the animals were not abused and proper procedures followed. He said eating animals could also be seen as cruel, and yet it was widely accepted.
Vivo inked a 450 million ringgit (US$141 million) joint-venture deal in January to build the biotechnology center, including laboratories where trial medicines will be tested on animals. Its partners are state government-owned Melaka Biotech Holdings and local firm Vanguard Creative Technologies.
Malaysia's Society for the Prevention of Cruelty to Animals slammed Mohamad Ali's statement, saying it had not been scientifically proven that animal testing was necessary to develop medicine.
"Our primates will be snatched from the forests to be tested for what? Animal testing really leads to nowhere," group representative Christine Chin-Radford said.
"We are not confident at all that ... their welfare will be looked at properly. We are concerned about this exportation of cruelty to Malaysia," Chin-Radford said.
The plans by India's Vivo BioTech Ltd to set up a biotechnology center in southern Malacca state has come under fire by activists because it will conduct tests on dogs and primates to make medicines. The activists said Malaysia has no regulations on animal research, which could lead to test subjects being abused.
But Malacca Chief Minister Mohamad Ali Rustam said the lab had received state approval, and animal testing was necessary to make drugs. The project is still in the planning phase.
"God created animals for the benefits of human beings. That's why he created rats and monkeys ... We cannot test on human beings," he said. "This is the way it has to be. God created monkeys, and some have to be tested."
He said Malaysian agencies, such as the wildlife department, could monitor that the animals were not abused and proper procedures followed. He said eating animals could also be seen as cruel, and yet it was widely accepted.
Vivo inked a 450 million ringgit (US$141 million) joint-venture deal in January to build the biotechnology center, including laboratories where trial medicines will be tested on animals. Its partners are state government-owned Melaka Biotech Holdings and local firm Vanguard Creative Technologies.
Malaysia's Society for the Prevention of Cruelty to Animals slammed Mohamad Ali's statement, saying it had not been scientifically proven that animal testing was necessary to develop medicine.
"Our primates will be snatched from the forests to be tested for what? Animal testing really leads to nowhere," group representative Christine Chin-Radford said.
"We are not confident at all that ... their welfare will be looked at properly. We are concerned about this exportation of cruelty to Malaysia," Chin-Radford said.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.